Forest Labs leads drug stocks south
April 08, 2010 at 10:42 AM EDT
Forest Laboratories lead drug stocks south early, as shares of the drug-maker lose ground on news that an FDA advisory panel has recommended the agency not approve Forest's new pulmonary drug Daxas.